A Cost Model for a Low-Threshold Clinic Treating Opioid Use Disorder

被引:0
|
作者
Wakeman, Sarah E. [1 ]
Powell, Elizabeth [2 ]
Shehab, Syed [3 ]
Herman, Grace [4 ]
Kehoe, Laura [1 ]
Kaplan, Robert S. [3 ,5 ]
机构
[1] Massachusetts Gen Hosp, Dept Med, Boston, MA USA
[2] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA USA
[3] Harvard Univ, Cambridge, MA USA
[4] Univ Buffalo, Jacobs Sch Med, Buffalo, NY USA
[5] Harvard Sch Business, Boston, MA 02163 USA
关键词
BUPRENORPHINE; PEOPLE;
D O I
10.1007/s11414-023-09853-4
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The US fee-for-service payment system under-reimburses clinics offering access to comprehensive treatments for opioid use disorder (OUD). The funding shortfall limits a clinic's ability to expand and improve access, especially for socially marginalized patients with OUD. New payment models, however, should reflect the high variation in cost for using a clinic's clinical and voluntary psychosocial and recovery support services. The authors applied time-driven activity-based costing, a patient-level, micro-costing approach, to estimate the cost at an outpatient clinic that delivers medication for opiate used disorder (MOUD) and voluntary psychosocial and recovery support services. Much of the cost variation could be explained by classifying patients into three archetypes: (1) light touch (1-3 visits): no significant co-occurring psychiatric illness, stable housing, and easy to connect for ongoing OUD treatment in a traditional outpatient setting; (2) standard (average of 8 visits): initially requires an integrated team-based care model but soon stabilizes for transition to community-based outpatient care; (3) quad morbidity (> 20 visits): multiple co-occurring substance use disorders, unhoused, co-occurring medical and psychiatric complexity, and limited social supports. With the cost of the initial visit set at an indexed value of 100, an average light touch patient had a cost of 352, a standard patient was 718, and a quad morbidity patient was 1701. The cost structure revealed by this analysis provides the foundation for alternative payment models that would enable new MOUD clinics, staffed with multi-disciplinary care teams, and located for convenient access by high-risk patients, to be established and sustained.
引用
收藏
页码:22 / 30
页数:9
相关论文
共 50 条
  • [1] The Mobile Overdose Response Program: A mobile, low-threshold opioid use disorder treatment model in Philadelphia
    Lowenstein, Margaret
    Popova, Ellena
    Jalloh, Aminata
    Mazzella, Silvana
    Botcheos, Denise
    Bertocchi, Jennifer
    Westfahl, Shawn
    Garcia, Kristine Pamela
    Truchil, Rachael
    Chertok, Judy
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2024, 164
  • [2] Predictors of engagement and retention in care at a low-threshold substance use disorder bridge clinic
    Wakeman, Sarah E.
    McGovern, Sydney
    Kehoe, Laura
    Kane, Martha T.
    Powell, Elizabeth A.
    Casey, Sarah K.
    Yacorps, Giovanie M.
    Irvin, Jasmine R.
    Rodriguez, Windia
    Regan, Susan
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 141
  • [3] Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C Treatment
    Hill, Kristi
    Nussdorf, Laura
    Mount, Julia D.
    Silk, Rachel
    Gross, Chloe
    Sternberg, David
    Bijole, Phyllis
    Jones, Miriam
    Kier, Randy
    Mccullough, Dana
    Mathur, Poonam
    Kottilil, Shyam
    Masur, Henry
    Kattakuzhy, Sarah
    Rosenthal, Elana S.
    JOURNAL OF ADDICTION MEDICINE, 2022, 16 (01) : 10 - 17
  • [4] Patient experiences with a transitional, low-threshold clinic for the treatment of substance use disorder: A qualitative study of a bridge clinic
    Snow, Rachel L.
    Simon, Rachel E.
    Jack, Helen E.
    Oller, Devin
    Kehoe, Laura
    Wakeman, Sarah E.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2019, 107 : 1 - 7
  • [5] Linkage to Care Outcomes Following Treatment in A Low-Threshold Substance Use Disorder Bridge Clinic
    Casey, Sarah K.
    Howard, Sydney
    Regan, Susan
    Romero, Alison
    Powell, Elizabeth A.
    Kehoe, Laura
    Kane, Martha T.
    Wakeman, Sarah E.
    SUBSTANCE USE & ADDICTION JOURNAL, 2025, 46 (02): : 247 - 255
  • [6] Characterizing the social support and functioning of a low-threshold medication for opioid use disorder treatment cohort at intake
    Oles, William
    Alexander, Marcus
    Kumar, Navin
    Howell, Benjamin
    O'Connor, Patrick G.
    Madden, Lynn M.
    Barry, Declan T.
    BMC PSYCHIATRY, 2022, 22 (01)
  • [7] In the Clinic Opioid Use Disorder
    Taylor, Jessica L.
    Samet, Jeffrey H.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (01) : ITC1 - U33
  • [8] Pharmacotherapies for treating opioid use disorder
    Nguyen, Thomas A.
    Hahn, Jennie H.
    Strakowski, Stephen M.
    CNS SPECTRUMS, 2013, 18 (06) : 289 - 295
  • [9] Treating patients with opioid use disorder
    Lopes, John E.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (10): : 10 - 11
  • [10] Effectiveness and Safety of Low-Threshold Opioid-Agonist Treatment in Hard-To-Reach Populations with Opioid Dependence
    Chalabianloo, Fatemeh
    Ohldieck, Christian
    Haaland, oystein A.
    Fadnes, Lars Thore
    Johansson, Kjell Arne
    EUROPEAN ADDICTION RESEARCH, 2022, 28 (03) : 199 - 209